TABLE 2

Participant-Reported Clinical Variables

Clinical VariablesNo. ResponsesFinding, Mean ± SD or No. (%)
Glycemic control
 HbA1c3005.67% ± 0.66%
 CGM average, mg/dLa137104 ± 16
 CGM SD, mg/dLa11528 ± 12
 Blood glucose meter average, mg/dLb77106 ± 21
 Blood glucose meter SD, mg/dLb3636 ± 35
 Insulin daily dose, U/kg per d2820.40 ± 0.19
 Insulin % basal19864% ± 21%
Adverse events
 Diabetes-related hospitalizations, persons per yc3007 (2)
  DKA4 (1)
  Hypoglycemia2 (1)
  Other4 (1)
 Diabetes-related emergency encounters, persons per y30110 (3)
  DKA3 (1)
  Hypoglycemia2 (1)
  Other7 (2)
 Hypoglycemia with seizure and/or coma, persons per y2987 (2)
 Hypoglycemia requiring help from others, adults per y17420 (12)
 Hypoglycemia requiring glucagon, persons per yd29911 (4)
 Symptomatic hypoglycemic episodes, persons per mo297
  092 (31)
  1–5112 (38)
  5–1040 (13)
  10–2030 (10)
  ≥2123 (8)
 Monthly symptomatic hypoglycemic episodes1016.1 (8.5)
Lipids, fasting
 Total cholesterol, mg/dL79234 ± 89
  Total cholesterol ≥200 mg/dL47 (60)
 LDLc, mg/dL81147 ± 83
  >130 mg/dL39 (48)
 HDLc, mg/dL8074 ± 21
  <35 mg/dL0 (0)
 TG, mg/dL8174 ± 37
  >150 mg/dL5 (6)
 Dyslipidemia (TG >130 mg/dL, LDLc >130, or HDLc <35 mg/dL)8251 (62)
  • a Obtained over 20 ± 18 d.

  • b Obtained over 20 ± 18 d; 8 ± 3 measurements per day.

  • c Data overlap because some participants reported events in different categories.

  • d Only assessed in adults because help from others is always required in children.